Study Finds Broad Support for Rationing of Some Types of Cancer Care (media/asco link/other)

Blogger's Note: read the full text for context

media


Newswise — PHILADELPHIA – The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don’t improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).
The Penn Medicine team surveyed 326 adult cancer patients receiving treatment at Penn’s Abramson Cancer Center, a random sample of 891 adults in the general public, and 250 oncologists across the United States during 2012 to probe their opinions about tactics for controlling costs associated with cancer care......


Other Abstracts in this Sub-Category:

	1. Financial distress, communication, and cancer treatment decision making: Does cost matter? Meeting: 2013 ASCO Annual Meeting Abstract No: 6506 First Author: Y. Zafar Category: Health Services Research - Cost
	2. Determining value of high cost cancer therapies and discussing cost of cancer care: The patient perspective. Meeting: 2013 ASCO Annual Meeting Abstract No: 6512 First Author: S. Rajguru Category: Health Services Research - Cost
	3. Adoption of robot-assisted surgery and its impact on treatment patterns for newly diagnosed localized prostate cancer. Meeting: 2013 ASCO Annual Meeting Abstract No: 6513 First Author: Y. T. Shih Category: Health Services Research - Cost